Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)-Reference-Cited by-同舟云学术

Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)

Published:2019-02 Issue:4 Volume:123 Page:592-597
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Lip Gregory Y.H.^ORCID,Merino Jose L.,Banach Maciej^ORCID,de Groot Joris R.,Maier Lars S.,Themistoclakis Sakis,Boriani Giuseppe^ORCID,Jin James,Melino Michael,Winters Shannon M.^ORCID,Goette Andreas

Funder

Daiichi Sankyo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Relation of nonvalvular atrial fibrillation to body mass index (from the SPORTIF Trials);Proietti;Am J Cardiol,2016

2. Overweight and obesity in patients with atrial fibrillation: sex differences in 1-year outcomes in the EORP-AF General Pilot Registry;Boriani;J Cardiovasc Electrophysiol,2018

3. Is There an obesity paradox for outcomes in atrial fibrillation? A systematic review and meta-analysis of non-vitamin k antagonist oral anticoagulant trials;Proietti;Stroke,2017

4. Complex relationship of obesity and obesity paradox in heart failure - higher risk of developing heart failure and better outcomes in established heart failure;Alagiakrishnan;Ann Med,2016

5. The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review;De Caterina;Clin Res Cardiol,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity;JAMA Cardiology;2024-07-01

2. Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-27

3. Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials;Thrombosis Research;2024-06

4. Safety and efficacy of direct oral anticoagulants in comparison to warfarin in obese patients with atrial fibrillation: A systematic review and meta‐analysis;Health Science Reports;2024-04

5. Elective cardioversion at a district general hospital: a retrospective evaluation of outcomes;British Journal of Nursing;2024-02-08